Headlines
New Drugs
Drug Alert
EMEA
FDA
Health Canada
MHRA
NICE
TGA
MedSafe
AZ Guide
Medicine
News
Drugs
Xagena
Medicine
Xapedia
Drugs
Medicine
Italy
Photo Gallery
iv Bisphosphonates and osteonecrosis of the jaw: elevated risk for patients with underlying malignant condition
Rosiglitazone associated with parotid gland enlargement
Aripiprazole may cause neuroleptic malignant syndrome
Parkinson's disease: medical management of Levodopa-associated motor complications
EMEA recommends withdrawal of medicinal products containing Veralipride
Increased incidence of fractures in female patients who received long-term treatment with Avandia for type 2 diabetes mellitus
The benefit-risk ratio of Rosiglitazone therapy is not defined
Review of data indicates that Phenylephrine requires further study to demonstrate efficacy and safety
Potentially life threatening side effects combining Aliskiren with Valsartan
EMEA recommends Acomplia must not be used in patients on antidepressants or with major depression
Frontotemporal dementia: a new gene mutation identified
ERF, a new target for Duchenne muscular dystrophy drug therapy
Y2R inhibitor could reduce abdominal obesity
Mirtazapine and blood dyscrasias
Clozapine and myocarditis
Saxagliptin added to Metformin improves glycemic control in patients with type 2 diabetes compared to Metformin alone
FDA has approved Lyrica for treatment of fibromyalgia
Nexavar significantly extends overall survival in hepatocellular carcinoma patients
Denosumab reduces the progression of bone erosion
Alcohol intake associated with decreased risk of developing rheumatoid arthritis
IKBKE gene linked to breast cancer
Chronic iron overload: Exjade may cause acute renal failure and cytopenias
B-cell depletion therapy for patients with refractory systemic lupus erythematosus
Belimumab improves symptoms in 46 percent of systemic lupus erythematosus patients
Letrozole is active in ER-positive ovarian cancer
FDA has approved Letairis for treatment of pulmonary arterial hypertension
Lapatinib in brain metastases associated with breast cancer
Lapatinib in combination with Paclitaxel as first-line treatment for patients with metastatic or relapsed advanced breast cancer
MAGE-A3 ASCI: clinical activity of a novel cancer immunotherapeutic in patients with non-small cell lung cancer
Advanced renal cell carcinoma: Temsirolimus improves overall survival
Losartan treats muscular dystrophy in mice
Acetylsalicylic acid saves lives of cancer patients suffering myocardial infarction
SORL1, a new gene for late-onset Alzheimer's disease
Telomere length may predict risk of coronary heart disease in middle-aged men
FDA: safety information on diabetes drug Rosiglitazone
FDA has approved Lybrel, a contraceptive for continuous use
Avandia linked to risk of myocardial infarction and heart-related deaths
Pharmacogenetics of antileukemic drug toxicity
Primary gastrointestinal stromal tumor: Imatinib decreases cancer recurrence
FDA has approved Neupro patch for treatment of early Parkinson's disease
New warnings about suicidal thinking, behavior in young adults who take antidepressant medications
Avastin linked to tracheoesophageal fistula
EPCA-2 prostate cancer test more accurate than PSA testing
Huntington’s disease onset linked to faulty DNA repair
CYP1A2 inhibitors may lead to substantial increases in Tizanidine blood concentrations
Cancer: novel regulation of the common tumor suppressor PTEN
FDA has approved Altabax for topical treatment of impetigo
Novartis has agreed to stop selling Zelnorm in US
FDA has approved HepaGam B to prevent hepatitis B reinfection in liver transplant patients
Multiple myeloma: low-dose Dexamethasone combined with Lenalidomide prolongs survival compared with high-dose Dexamethasone
Humira is effective in psoriasis
Baraclude: occurrence of a resistant HIV variant in a patient co-infected with HIV and HBV
EMEA: Enzastaurin granted orphan drug status for treatment of diffuse large B-cell lymphoma
Parkinson's disease: Pergolide withdrawn for serious damage to heart valves
A new PPAR-alpha agonist shows no advantages compared with Fenofibrate
Torcetrapib fails to slow progression of coronary disease
METEOR Trial: Rosuvastatin effective at halting early atherosclerosis
COURAGE Trial: percutaneous coronary intervention adds no benefit over optimal medical therapy alone
ERASE Trial: CSL-11, a drug that mimics HDL, has mixed effect on coronary atherosclerosis
Pioglitazone, a diabetes drug, shows promise for preventing brain injury from radiation therapy
No benefit for liver cancer patients from long-acting Octreotide
FDA has approved Soliris for paroxysmal nocturnal hemoglobinuria
FDA requests label change for all sleep disorder drug products
ECG abnormalities linked with increased risk of cardiovascular events in women
FDA has approved Tykerb for advanced breast cancer patients
Increased incidence of fractures in women who received long-term treatment with Pioglitazone
Tumor-free breast tissue can have precancerous changes
Carnosinase 1 gene associated with severe kidney failure in diabetes
Pancreatic cancer surgery five-year survivors 65 and up live nearly as long as anyone
Computed tomography screening may increase rate of lung cancer diagnosis, but not decrease risk of death
FDA has approved Humira for Crohn's disease
ADHD Drugs linked to cardiovascular and psychiatric adverse events
Multple sclerosis: parasite infection may be of benefit
Osteosarcoma: no benefit to increasing dose intensity of chemotherapy
Recentin, a new angiogenesis inhibitor, can reduce size of glioblastoma
Gemcitabine appears to delay cancer recurrence following surgery for pancreatic cancer
Levofloxacin may cause dysglycemia and liver disorders
Alphanate in the treatment of von Willebrand disease
FDA has restricted use of antibiotic Ketek
Prevalence of congenital heart disease has increased strikingly in adults
Genetics and lifestyle interact to increase risk for age-related macular degeneration
Higher folate levels linked to reduced risk for Alzheimer's disease
Long-term behavioral and neurological problems associated with prenatal exposure to cocaine
Milk eliminates cardiovascular health benefits of tea
Valganciclovir for chronic fatigue syndrome to be tested
Hypertension, prehypertension in young linked with heart enlargement
Genomic alterations in the stroma of head and neck squamous cell carcinoma
NT-proBNP level was associated with a greater risk of cardiovascular events or death
Improved adherence to statins and beta-blockers associated with longer survival following myocardial infarction
Excess weight and adult weight gain increase the risk of dying from prostate cancer
Antibody therapy prevents type 1 diabetes in mouse model
Isolation of broad potential stem cells from the amniotic fluid
A novel pathway by which the anti-cancer gene p53 protects a damaged cell from becoming cancer uncovered
Risk factors for diabetes following liver transplant
A novel gene mutation associated with Wilms tumor
MTWA test can predict which patients will get life-saving benefit from ICDs, and which won't
Interferon-treated hepatitis C patients likely to experience retinopathy
Acute ST-elevation myocardial infarction: Pexelizumab does not appear to offer benefit in patients undergoing PCI
Cough and phlegm cause fourfold increase in COPD incidence
Heart failure: genetic mutation alters response to beta-blockers
Pagine successive
1
2
3
[
4
]
5
6
7
8
9
10
»
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
Annunci Google:
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions